Breath analysis for relapsing polychondritis assessed by ion mobility spectrometry

International Journal for Ion Mobility Spectrometry

Volumn 18, Issue 3-4, 2015, Pages 177-183

  Usuba, Ayano ^a   Handa, Hiroshi ^a   Inoue, Teppei ^a   Azagami, Shinya ^a   Yamano, Yoshihisa ^a   Mineshita, Masamichi ^a   Miyazawa, Teruomi ^a   Baumbach, Jörg Ingo ^b  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b REUTLINGEN UNIVERSITY   (Germany)

Author keywords

Breath analysis 1; Relapsing polychondritis 2; Volatile organic compound 3

Indexed keywords

EID: 84943355432     PISSN: 14356163     EISSN: 18654584     Source Type: Journal    
DOI: 10.1007/s12127-015-0182-z     Document Type: Article

References (24)

1. McAdam LP, O'Hanlan MA, Bluestone R, Pearson CM (1976) Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine (Baltimore) 55(3):193–215
2. Damiani JM, Levine HL (1979) Relapsing polychondritis–report of ten cases. Laryngoscope 89(6 Pt 1):929–946
3. Ernst A1, Rafeq S, Boiselle P, Sung A, Reddy C, Michaud G, Majid A, Herth FJ, Trentham D (2009) Relapsing polychondritis and airway involvement. Chest 135(4):1024–1030
4. Sarodia BD1, Dasgupta A, Mehta AC. Sarcodia BD, Dasgupta A, Mehta AC (1999) Management of airway manifestations of relapsing polychondritis: case reports and review of literature. Chest 116(6):1669–1675
5. Segel MJ, Godfrey S, Berkman N (2004) Relapsing polychondritis: reversible airway obstruction is not always asthma. Mayo Clin Proc 79(3):407–409
6. Westhoff M, Litterst P, Freitag L, Urfer W, Bader S, Baumbach JI (2009) Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study. Thorax 64(9):744–748
7. Handa H, Usuba A, Maddula S, Baumbach JI, Mineshita M, Miyazawa T (2014) Exhaled breath analysis for lung cancer detection using ion mobility spectrometry. PLoS One 9:9(12)
8. Westhoff M, Litterst P, Freitag L, Baumbach JI (2007) Ion mobility spectrometry in the diagnosis of sarcoidosis: results of a feasibility study. J Physiol Pharmacol 58 Suppl 5(Pt 2):739–751
9. Bunkowski A1, Bödeker B, Bader S, Westhoff M, Litterst P, Baumbach JI (2009) MCC/IMS signals in human breath related to sarcoidosis-results of a feasibility study using an automated peak finding procedure. J Breath Res 3(4):046001
10. Westhoff M, Litterst P, Maddula S, Bödecker B, Rahmann S, Davies AN, Baumbach JI (2010) Differentiation of chronic obstructive pulmonary disease (COPD) including lung cancer from healthy control group by breath analysis using ion mobility spectrometry. Int J Ion Mobil Spectrom 13:131–139
11. Bessa V, Darwiche K, Teschler H, Sommerwerck U, Rabis T, Baumbach JI, Freitag L (2011) Detection of volatile organic compounds (VOCs) in exhaled breath of patients with chronic obstructive pulmonary disease (COPD) by ion mobility spectrometry. Int J Ion Mobil Spectrom 14:7–13
12. Fens N, Zwinderman AH, van der Schee MP, de Nijs SB, Dijkers E, Roldaan AC, Cheung D, Bel EH, Sterk PJ (2009) Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma. Am J Respir Crit Care Med 180(11):1076–1082
13. Jünger M1, Bödeker B, Baumbach JI (2010) Peak assignment in multi-capillary column-ion mobility spectrometry using comparative studies with gas chromatography–mass spectrometry for VOC analysis. Anal Bioanal Chem 396(1):471–482
14. Baumbach JI (2006) Process analysis using ion mobility spectrometry.Anal. Bioanal Chem 384(5):1059–1070
15. Bunkowski A, Maddula S, Davies AN, Westhoff M, Litterst P, Bödecker B, Baumbach JI (2006) One-year time series of investigations of analytes within human breath using ion mobility spectrometry. Int J Ion Mobil Spectrom 13:141–148
16. Bödeker B, Davies AN, Maddula S, Baumbach JI (2010) Biomarker validation—room air variation during human breath investigations. Int J Ion Mobil Spectrom 13:177–184
17. Maddula S, Blank LM, Schmid A, Baumbach JI (2009) Detection of volatile metabolites of Escherichia coli by multi capillary column coupled ion mobility spectrometry. Anal Bioanal Chem Jun 394(3):791–800
18. Bödeker B, Vautz W, Baumbach JI (2008) Peak Finding and Referencing in MCC/IMS - Data. Int J Ion Mobil Spectrom 11:83–88
19. Bödeker B, Vautz W, Baumbach JI (2008) Peak Comparison in MCC/IMS – Data – Searching for potential biomarkers in human breath data. Int J Ion Mobil Spectrom 11:89–93
20. Bödeker B, Vautz W (2008) Baumbach JI (2008) Visualisation of MCC/IMS – Data. Int J Ion Mobil Spectrom 11:77–82
21. Maddula S, Rupp K, Baumbach JI (2012) Recommendation for an upgrade to the standard format in order to cross-link the GC/MSD and the MCC/IMS data. Int J Ion Mobil Spectrom 15:79–81
22. Sato T, Yamano Y, Tomaru U, Shimizu Y, Ando H, Okazaki T, Nagafuchi H, Shimizu J, Ozaki S, Miyazawa T, Yudoh K, Oka H, Suzuki N (2014) Serum level of soluble triggering receptor expressed on myeloid cells-1 as a biomarker of disease activity in relapsing polychondritis. Mod Rheumatol 24(1):129–136
23. Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, Olin AC, Plummer AL, Taylor DR, American Thoracic Society Committee on Interpretation of Exhaled Nitric Oxide Levels (FENO) for Clinical Applications (2011) An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med 184(5):602–615
24. Foidart JM, Abe S, Martin GR, Zizic TM, Barnett EV, Lawley TJ, Katz SI (1978) Antibodies to type II collagen in relapsing polychondritis. N Engl J Med 299(22):1203–1207